Schedule 13D ownership disclosure
Sonoma Pharmaceuticals Inc
Security class unavailable · CUSIP: 83558L105
Event date: 2018-11-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 571,428
- Percent of class
- 8.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-069403
- Form type
- SC 13D
- Filer
- Montreux Equity Partners V, L.P.
- CIK
- CIK 1548152
- Filed
- Nov 20, 2018
- Reporting period
- Nov 19, 2018
- Description
- Schedule 13D beneficial ownership